Cassava Sciences Equity 2024

Cassava Sciences Aktienanalyse

What does Cassava Sciences do?

Cassava Sciences Inc. is a biotechnology company founded in 1998. Its headquarters is in Austin, Texas. The company aims to research the inflammatory causes of neurodegenerative diseases, such as Alzheimer's, and develop new treatment options and medications. Cassava Sciences' business model is based on the development and commercialization of innovative therapies through research, clinical trials, and partnerships with other companies. The company focuses on developing treatment options for Alzheimer's disease. Cassava Sciences consists of various divisions that work closely together. One focus of the company is researching and developing new medications for the treatment of Alzheimer's. The company collaborates closely with scientists to develop new treatment options. Another important aspect of Cassava Sciences is conducting clinical trials to test the effectiveness and safety of the developed medications. The company collaborates with globally renowned research institutions. One of Cassava Sciences' products is the medication PTI-125, which was developed for the treatment of Alzheimer's. The medication aims to target the inflammatory causes of the disease and slow down its progression. PTI-125 is currently in Phase IIb of clinical testing and shows promising results. In recent years, Cassava Sciences has formed several partnerships with other companies to advance research and development of new treatment options. For example, the company collaborates with Pfizer and AbbVie. The history of Cassava Sciences is marked by intensive research activity and the goal of improving the quality of life for people with Alzheimer's disease. The company's research findings have been presented at scientific conferences and received significant media attention. In summary, Cassava Sciences is an innovative biotechnology company focused on researching and developing treatment options for Alzheimer's. In addition to developing new medications, the company also conducts clinical trials and collaborates with other companies to advance research. Cassava Sciences sees itself as a pioneer in the field of Alzheimer's therapy and aims to significantly improve the quality of life for people with this condition. Cassava Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Cassava Sciences's Equity

Cassava Sciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cassava Sciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cassava Sciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cassava Sciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cassava Sciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cassava Sciences stock

What is the equity of Cassava Sciences this year?

Cassava Sciences has equity of 137.47 M USD this year.

What was the equity of Cassava Sciences compared to the previous year?

The equity of Cassava Sciences has increased/decreased by -39.57% decreased compared to the previous year.

What impact does a high equity have on investors of Cassava Sciences?

A high equity is advantageous for investors of Cassava Sciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Cassava Sciences?

A low equity can be a risk for investors of Cassava Sciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Cassava Sciences affect the company?

An increase in equity of Cassava Sciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Cassava Sciences affect the company?

A reduction in equity of Cassava Sciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Cassava Sciences?

Some factors that can affect the equity of Cassava Sciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Cassava Sciences so important for investors?

The equity of Cassava Sciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Cassava Sciences take to change the equity?

To change equity, Cassava Sciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Cassava Sciences pay?

Over the past 12 months, Cassava Sciences paid a dividend of 5.25 USD . This corresponds to a dividend yield of about 181.66 %. For the coming 12 months, Cassava Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cassava Sciences?

The current dividend yield of Cassava Sciences is 181.66 %.

When does Cassava Sciences pay dividends?

Cassava Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cassava Sciences?

Cassava Sciences paid dividends every year for the past 0 years.

What is the dividend of Cassava Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cassava Sciences located?

Cassava Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cassava Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cassava Sciences from 12/24/2012 amounting to 0.75 USD, you needed to have the stock in your portfolio before the ex-date on 12/13/2012.

When did Cassava Sciences pay the last dividend?

The last dividend was paid out on 12/24/2012.

What was the dividend of Cassava Sciences in the year 2023?

In the year 2023, Cassava Sciences distributed 0 USD as dividends.

In which currency does Cassava Sciences pay out the dividend?

The dividends of Cassava Sciences are distributed in USD.